Sanford C. Bernstein set a €83.00 ($96.51) target price on Fresenius SE & Co KGaA (FRA:FRE) in a research note issued to investors on Friday, September 21st. The firm currently has a buy rating on the stock.

A number of other brokerages also recently commented on FRE. HSBC set a €74.00 ($86.05) target price on shares of Fresenius SE & Co KGaA and gave the stock a neutral rating in a research note on Monday, September 3rd. Kepler Capital Markets set a €82.00 ($95.35) price objective on shares of Fresenius SE & Co KGaA and gave the company a buy rating in a research note on Wednesday, June 6th. Commerzbank set a €79.00 ($91.86) price objective on shares of Fresenius SE & Co KGaA and gave the company a buy rating in a research note on Wednesday, June 6th. Independent Research set a €80.00 ($93.02) price objective on shares of Fresenius SE & Co KGaA and gave the company a buy rating in a research note on Tuesday, July 31st. Finally, Barclays set a €80.00 ($93.02) price objective on shares of Fresenius SE & Co KGaA and gave the company a buy rating in a research note on Wednesday, August 1st. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the stock. The company has an average rating of Buy and a consensus target price of €77.79 ($90.46).

Shares of FRE stock traded down €1.50 ($1.74) on Friday, reaching €66.28 ($77.07). 1,713,451 shares of the stock were exchanged. Fresenius SE & Co KGaA has a twelve month low of €60.16 ($69.95) and a twelve month high of €80.00 ($93.02).

Fresenius SE & Co KGaA Company Profile

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

Read More: Put Option

Analyst Recommendations for Fresenius SE & Co KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.